Molecular-clinical correlations in children and adults with fragile X syndrome. 1993

L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
Child Development Unit, Children's Hospital, Denver, CO 80218.

BACKGROUND Fragile X syndrome is the most commonly known inherited form of mental retardation. The intellectual abilities range from a normal IQ with learning disabilities to severe mental retardation. In males, there is a tendency for IQ decline in childhood. The purpose of this study was to correlate variations of the molecular cytosine guanine guanine (CGG) amplification in the fragile X mental retardation-1 (FMR-1) gene with the clinical findings, including IQ and physical features. METHODS Full-scale IQ and cytogenetic results in 116 individuals with the FMR-1 mutation were studied. The IQ testing was performed with age-appropriate standardized tests. Physical features were summarized in a physical index score for each patient. The FMR-1 results were determined with the OX1.9 probe and the following system was used: P1 indicates premutation; P2, large premutation to small full mutation; P3, full mutation; and P4, mosaic. CONCLUSIONS The findings showed that those females with a small insert in the P1 range had a significantly higher IQ than other heterozygotes (P2, P3, and P4 categories). P4 males had a significantly higher IQ than P2 or P3 males. In cross-sectional age comparisons, the slope of the IQ decline was greater in P2 males than in P4 or P3 males.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007361 Intelligence Tests Standardized tests that measure the present general ability or aptitude for intellectual performance. Mental Tests,Raven Test,Raven's Progressive Matrices,Intelligence Test,Mental Test,Raven Progressive Matrices,Ravens Progressive Matrices,Test, Intelligence,Test, Mental,Test, Raven
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008967 Molecular Biology A discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules. Biochemical Genetics,Biology, Molecular,Genetics, Biochemical,Genetics, Molecular,Molecular Genetics,Biochemical Genetic,Genetic, Biochemical,Genetic, Molecular,Molecular Genetic
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females

Related Publications

L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
December 1995, Therapeutische Umschau. Revue therapeutique,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
August 1996, American journal of medical genetics,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
April 1999, American journal of medical genetics,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
January 2008, The Journal of the Egyptian Public Health Association,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
November 1995, Pediatric research,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
October 1989, Tijdschrift voor kindergeneeskunde,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
January 1986, Indian journal of pediatrics,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
November 1993, Annales de pediatrie,
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
January 2023, Colombia medica (Cali, Colombia),
L W Staley, and C E Hull, and M M Mazzocco, and S N Thibodeau, and K Snow, and V L Wilson, and A Taylor, and L McGavran, and D Weiner, and J Riddle
February 1997, The Western journal of medicine,
Copied contents to your clipboard!